Heussler, Helen

KAT6A Syndrome: genotype–phenotype correlation in 76 patients with pathogenic KAT6A variants

Kennedy, J., Goudie, D., Blair, E., Chandler, K., Joss, S., McKay, V., Green, A., Armstrong, R., Lees, M., Kamien, B., et al. (2019) · Genetics in Medicine

Genomics and Rare DiseasesGenetics and Neurodevelopmental Disorders

Cited by 107

A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome

Heussler, H., Cohen, J., Silove, N., Tich, N., Bonn-Miller, M. O., Du, W., O’Neill, C., & Sebree, T. (2019) · Journal of Neurodevelopmental Disorders

Genetics and Neurodevelopmental DisordersCannabis and Cannabinoid Research

Cited by 106

Clinical outcomes and associated predictors of early intervention in autism spectrum disorder: a study protocol

Masi, A., Dissanayake, C., Alach, T., Cameron, K., Fordyce, K., Frost, G., Grove, R., Heussler, H., Silove, N., Sulek, R., et al. (2021) · BMJ Open

Autism Spectrum Disorder ResearchFamily and Disability Support Research

Cited by 14